...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: got this & sent a response/follow up minutes before …

KK2 - You mentioned the initial broker, who is that?

tada 

Share
New Message
Please login to post a reply